Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
88 participants
INTERVENTIONAL
2007-01-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis
NCT04706559
Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis
NCT00224432
Probiotics and Allergic Diseases
NCT01635738
The Effect of a Probiotic Intervention in Healthy Subjects and Patients With Atopic Dermatitis
NCT00550472
Probiotic on Atopic Dermatitis in Infant
NCT05286047
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lactobacillus sakei KCTC 10755BP
probiotic L sakei KCTC 10755BP
freeze-dried, 50,0000,0000 colony-forming units, twice daily, for 12 weeks
microcrystalline cellulose
microcrystalline cellulose (placebo)
freeze-dried, 50,0000,0000 colony-forming units, twice daily, for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
probiotic L sakei KCTC 10755BP
freeze-dried, 50,0000,0000 colony-forming units, twice daily, for 12 weeks
microcrystalline cellulose (placebo)
freeze-dried, 50,0000,0000 colony-forming units, twice daily, for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a total SCORAD score above 25
* a change in a total SCORAD score of not more than 10% within 2 weeks
Exclusion Criteria
2 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yeungnam University Hospital
OTHER
Korea Research Institute of Bioscience & Biotechnology
OTHER_GOV
Gachon University Gil Medical Center
OTHER
Chungbuk National University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Pediatrics, College of Medicine, Chungbuk National University, Korea
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Youn-Soo Hahn, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Pediatrics, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Korea,
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chungbuk National University Hospital
Cheongju-si, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS 7403-179
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.